1. Home
  2. IPHA vs RDNW Comparison

IPHA vs RDNW Comparison

Compare IPHA & RDNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPHA
  • RDNW
  • Stock Information
  • Founded
  • IPHA 1999
  • RDNW 2013
  • Country
  • IPHA France
  • RDNW United States
  • Employees
  • IPHA N/A
  • RDNW N/A
  • Industry
  • IPHA Biotechnology: Pharmaceutical Preparations
  • RDNW EDP Services
  • Sector
  • IPHA Health Care
  • RDNW Technology
  • Exchange
  • IPHA Nasdaq
  • RDNW Nasdaq
  • Market Cap
  • IPHA 160.1M
  • RDNW 147.3M
  • IPO Year
  • IPHA 2019
  • RDNW N/A
  • Fundamental
  • Price
  • IPHA $2.18
  • RDNW $3.53
  • Analyst Decision
  • IPHA Hold
  • RDNW
  • Analyst Count
  • IPHA 2
  • RDNW 0
  • Target Price
  • IPHA $2.00
  • RDNW N/A
  • AVG Volume (30 Days)
  • IPHA 12.3K
  • RDNW 29.6K
  • Earning Date
  • IPHA 09-17-2025
  • RDNW 11-11-2025
  • Dividend Yield
  • IPHA N/A
  • RDNW N/A
  • EPS Growth
  • IPHA N/A
  • RDNW N/A
  • EPS
  • IPHA N/A
  • RDNW N/A
  • Revenue
  • IPHA $14,839,695.00
  • RDNW $1,109,200,000.00
  • Revenue This Year
  • IPHA $50.89
  • RDNW N/A
  • Revenue Next Year
  • IPHA N/A
  • RDNW $7.73
  • P/E Ratio
  • IPHA N/A
  • RDNW N/A
  • Revenue Growth
  • IPHA N/A
  • RDNW N/A
  • 52 Week Low
  • IPHA $1.29
  • RDNW $1.46
  • 52 Week High
  • IPHA $3.51
  • RDNW $7.06
  • Technical
  • Relative Strength Index (RSI)
  • IPHA 60.94
  • RDNW N/A
  • Support Level
  • IPHA $2.07
  • RDNW N/A
  • Resistance Level
  • IPHA $2.28
  • RDNW N/A
  • Average True Range (ATR)
  • IPHA 0.09
  • RDNW 0.00
  • MACD
  • IPHA 0.01
  • RDNW 0.00
  • Stochastic Oscillator
  • IPHA 69.70
  • RDNW 0.00

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About RDNW RideNow Group Inc. Class B Common Stock

RideNow Group Inc is a USA-based online retailer that allows consumers and dealers both to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience.

Share on Social Networks: